SCHEMBL9998474

SCHEMBL9998474

CCCCCc1ccc(C=CCOC(C)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 7/20 0.47
▸ ALDH1A1 P00352 2/20 0.46
▸ TNNC1 P63316 1/20 0.46
▸ THRA P10827 6/20 0.46
▸ CYSLTR2 Q9NS75 3/20 0.44
▸ CYSLTR1 Q9Y271 3/20 0.44
▸ PLA2G1B P04054 2/20 0.44
▸ TRPM2 O94759 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TRPA1 O75762 1/20 0.44
▸ TRPM8 Q7Z2W7 1/20 0.44
▸ ATG4B Q9Y4P1 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998473 1.00 THRB (0.47) THRBALDH1A1TNNC1THRACYSLTR2
SCHEMBL9998273 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9997695 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9998272 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9998123 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9997966 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9997968 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9998121 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9998003 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B
SCHEMBL9997698 0.99 TNNC1 (0.48) THRBALDH1A1TNNC1THRAPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 — — US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 THRB 926/4885ALDH1A1 160/4885TNNC1 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback